Clinical Trial Update: MT027 Cell Injection in Patients With Advanced Primary or Secondary Peritoneal Tumors [NA]

View source ↗

Summary

This clinical trial update describes MT027 cell injection being studied in patients with advanced primary or secondary peritoneal tumors. The study is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peritoneal Cancer
• Peritoneal Carcinomatosis

Drugs mentioned

• MT027

Snippet

Sponsor: Ruijin Hospital | Conditions: Peritoneal Tumor | NA | Status: RECRUITING